Harmony Baby Nutrition
OperatingMilk Care Co., Inc.
Biotech · Natick, MA
Baby formulas inspired by human milk
Financials
FY2023–FY2024 · from SEC filings · hover any figure for its sourceFigures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps markedA dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Team
9 people
Food scientist & infant nutrition expert. Launched 15+ clinical nutrition products end-to-end. Author of 18 scientific publications. Expertise in formulation, analytics, & bioactive optimization for probiotics & prebiotics. UFMG Food Science PhD.
Manufacturing & quality control leader. Led infant formula from characterization to industrial scale across 13 innovation projects. University professor since 2016. Author of 78 scientific papers & 21 book chapters. UFMG Food Science PhD.
Venture builder. Strategy & ops leader for early-stage science & nutrition startups. Led full-cycle VC investing for a $75M deep-tech fund. Experience building companies from 0 to launch. Chinese University of Hong Kong Global Economics & Finance BSc.
Physician & executive. 40 years in healthcare, including 19 in regulatory leadership at Wyeth, Pfizer, & Nestlé Nutrition. Expert in FDA strategy & clinical trial design. Philadelphia College of Osteopathic Medicine DO.
Pediatric gastroenterologist & food allergy expert. Co-Director, Pediatric GI Section, Food Allergy Center at Mass General Hospital for Children. Assistant Professor, Harvard Medical School. Harvard T.H. Chan MPH. UMass Chan Medical School MD.
Names and titles as disclosed on SEC Form C, WeFunder. Bios and photos come from the platform campaign page and may be out of date.
Reg CF annual-report compliance
never closed a Reg CF raise
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.